LIVING WITH PROSTATE CANCER: TREATMENT ,DIET& lifestyle TIPS
UNDERSTANDING 250 mg for Prostate Cancer Treatment Abirapro 250 mg for Prostate Cancer Treatment
Abirapro 250 mg (Abiraterone(Abiraterone Acetate 250 mg) is a hormonal cancer medication. It is used to treat advanced prostate cancer in men. It works by reducing testosterone levels, which helps stop or slow tumor growth. It is often taken with steroids to manage side effects, usually on an empty stomach.
Abiraterone acetate is a critical component of hormonal therapy used in the management of advanced prostate cancer. It acts as an androgen biosynthesis inhibitor, which reduces the production of testosterone.
WHAT IS ABIRAPRO 250 MG?
Abirapro 250 mg tablet contains Abiraterone acetate, an androgen biosynthesis inhibitor used to treat metastatic castration-resistant prostate cancer. It acts as an anti-neoplastic agent that reduces testosterone production, slowing cancer growth.
DRUG CLASSIFICATION
ACTIVE INGREDIENT: Abiraterone Acetate (250 mg)
DRUG CLASS: Androgen biosynthesis inhibitor, anti-androgen.
ACTION: Abiraterone Acetate inhibits the enzyme CYP17. This enzyme is responsible for producing testosterone in the testis and adrenal glands. By inhibiting it, the progression of prostate cancer is halted.
USAGE: usually taken in combination with prednisone to manage side effects like hypertension and low potassium.
PRESCRIPTION-BASED ANTI-CANCER MEDICATION
Abiraterone acetate, also known as abirapro, zytiga, and others, is a prescription-based oral medication. It is used to treat prostate cancer. This drug works by inhibiting the enzyme CYP17, which reduces the derivation of androgen. This process fuels the growth of prostate cancer cells.
PRESCRIPTION AND USAGE
Medical supervision: This medication requires a valid prescription from an oncologist.
Dosage form: Oral tablets are available.
Administration: It must be taken on an empty stomach.
WHAT ARE THE USES OF ABIRAPRO 250 MG?
Uses of Abirapro 250 mg are:
1. Abirapro 250 mg is used to treat newly diagnosed high-risk metastatic hormone-sensitive prostate cancer in adult men. It is used in combination with androgen deprivation therapy (ADT).
2. The treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. These men are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy. Chemotherapy is not yet clinically indicated for them.
3. The treatment of mCRPC in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
4. Management of metastatic high-risk castration-sensitive prostate cancer (CPC) with prednisone.
5. Treatment of newly diagnosed patients. It is often in combination with prednisone and androgen deprivation therapy.
One must adhere to their doctor’s prescription exactly when taking this medication. They should stick with the recommended dose and follow the length of time advised.
HOW DOES ABIRAPRO 250 MG WORK?
Abirapro 250 mg treats prostate cancer by inhibiting the CYP17 enzyme, which is responsible for the body to produce androgen. It reduces testosterone levels throughout the body, including the testes. This reduction also affects the adrenal glands and tumor tissues. It starves the cancer cells of the hormone they need to grow. As a result, the progression of the cancer slows down.
MECHANISM OF ACTION
Targeted enzyme inhibitors: Abirapro blocks the CYP17 enzyme, which is essential for androgen biosynthesis
Lowering fuel for cancer: it reduces testosterone levels significantly, which helps to stop or slow down the growth of prostate cancer cells.
Precautions: It can cause serious side effects, including liver issues, high blood pressure, fluid retention, and potassium loss.
WHAT ARE THE BENEFITS OF 250 ABIRAPRO 250 MG?
BENEFITS OF ABIRAPRO 250 MG:
HELPS SLOW CANCER PROGRESSION
Abirapro 250 mg is used as a long-term adjunct therapy. It inhibits the growth of cancer cells. This use reduces the risk of cancer coming back after surgery or radiation. It is considered a first-line treatment for early-stage hormone receptor-positive breast cancer. It also slows or stops the growth of tumors that have spread.
IMPROVES SURVIVAL RATE IN ADVANCED PROSTATE CANCER
Abirapro 250 mg is a targeted hormone therapy medication. It is used to treat advanced prostate cancer. This is achieved by inhibiting androgen production, which fuels tumor growth. It is used for:
1. Metastatic castration-resistant prostate cancer (mCRPC): for patients whose cancer has progressed despite traditional hormonal therapy or chemotherapy.
2. For newly diagnosed patients with metastatic high-risk castration-sensitive prostate cancer. They often receive combination treatment with androgen deprivation therapy (ADT) and prednisolone.
CONVENTIONAL ORAL THERAPY COMPARED TO SOME INJECTABLE TREATMENTS
Abirapro 250mg offers a convenient, non-invasive oral alternative to injectable androgen-lowering therapies. These are primarily for treating prostate cancer. As an oral tablet, it allows for home administration rather than frequent hospital visits for injections. This significantly enhances convenience. The medicine is taken orally, typically once a day, and should be taken on an empty stomach.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF ABIRAPRO 250 MG?
Some of the possible side effects of Abirapro250 mg are:
1. High blood pressure
2. Swelling in the legs
3. Low potassium levels
4. Fatigue
5. Nausea or digestive issues
6. Changes in liver function
Conclusion: Abirapro 250 mg is a crucial hormonal therapy medication primarily used in combination with prednisone to treat advanced, metastatic castration-resistant prostate cancer (mCRPC) and high-risk metastatic hormone-sensitive prostate cancer (mHSPC) in adult men.
FREQUENTLY ASKED QUESTIONS:
Can Abirapro 250 mg cure prostate cancer?
Abirapro 250 mg is a type of hormone therapy used to manage prostate cancer, but it is not a cure. It works by stopping the body from producing testosterone. This can slow the growth of cancer cells. It also helps to control symptoms and aids in living longer.
How long should Abirapro be taken?
Abirapro 250 mg is generally taken long-term to manage advanced prostate cancer. Treatment typically continues as long as the medication is effective and the side effects are manageable.
What happens if a dose is missed?
If you miss a dose of Abirapro 250 mg, the body’s level can drop below a therapeutic range. This decrease can make it less effective at controlling your condition.
Can it be taken with food?
It can generally be taken with or without food. However, taking it with food may help reduce the chance of stomach upset.
ALSO READ
- https://www.truemeds.in/medicine/abiratas-250-mg-tablet-120-tm-tacr1-000128
- https://www.hexahealth.com/blog/prostate-cancer-treatment-in-india
3. https://www.cancerresearchuk.org/about-cancer/prostate-cancer
4. https://www.healthline.com/health/prostate-cancer/prostate-cancer-medication

Leave a comment